The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer: A Systematic Review and Meta-analysis
Abstract
CONTEXT: Adjuvant chemotherapy (AC) improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. OBJECTIVE: To determine the relationship between time to AC and survival outcomes via a systematic review and meta-analysis. data sources: MEDLINE (1975 through January 2011), EMBASE, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched to identify studies that described the relationship between time to AC and survival. STUDY SELECTION: Studies were only included if the relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. DATA EXTRACTION: Hazard ratios (HRs) for overall survival and disease-free survival from each study were converted to a regression coefficient (β) and standard error corresponding to a continuous representation per 4 weeks of time to AC. The adjusted β from individual studies were combined using a fixed-effects model. Inverse variance (1/SE(2)) was used to weight individual studies. Publication bias was investigated using the trim and fill approach. RESULTS: We identified 10 eligible studies involving 15,410 patients (7 published articles, 3 abstracts). Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy. Six studies reported time to AC as a binary variable and 4 as 3 or more categories. Meta-analysis demonstrated that a 4-week increase in time to AC was associated with a significant decrease in both overall survival (HR, 1.14; 95% confidence interval [CI], 1.10-1.17) and disease-free survival (HR, 1.14; 95% CI, 1.10-1.18). There was no significant heterogeneity among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight. CONCLUSION: In a meta-analysis of the available literature on time to AC, longer time to AC was associated with worse survival among patients with resected colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
A Nonparametric “Trim and Fill” Method of Accounting for Publication Bias in Meta-Analysis
Duval, S., & Tweedie, R. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473905 · Cited by 2,955
Lacy, A. M., García-Valdecasas, J. C., Delgado, S., Castells, A., Taurá, P., Piqué, J. M., & Visa, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09290-5 · Cited by 2,441
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Benson, A. B., Schrag, D., Somerfield, M. R., Cohen, A. M., Figueredo, A. T., Flynn, P. J., Krzyzanowska, M. K., Maroun, J., McAllister, P., Van Cutsem, E., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.063 · Cited by 1,430
DQIS Research Group (2026) · PubMed · doi:10.5281/zenodo.21937949 · Cited by 1,327
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Kuebler, J. P., Wieand, H. S., O'Connell, M. J., Smith, R. E., Colangelo, L. H., Yothers, G., Petrelli, N. J., Findlay, M. P., Seay, T. E., Atkins, J. N., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2974 · Cited by 1,056
Chen, Z., King, W., Pearcey, R., Kerba, M., & Mackillop, W. J. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.11.016 · Cited by 424
Self-citationEffect of surgical removal on the growth and kinetics of residual tumor.
Gündüz, N., Fisher, B., & Saffer, E. (1979) · PubMed · Cited by 410
Figueredo, A., Charette, M. L., Maroun, J., Brouwers, M. C., & Zuraw, L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.087 · Cited by 348
Users' Guides to the Medical Literature: IV. How to Use an Article About Harm
Levine, M. (1994) · JAMA · doi:10.1001/jama.1994.03510440075037 · Cited by 311
Des Guetz, G., Nicolas, P., Perret, G.-Y., Morere, J.-F., & Uzzan, B. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.01.020 · Cited by 243
Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III
on behalf of the NACCP group*, Taal, B. G., Van Tinteren, H., & Zoetmulder, F. A. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2117 · Cited by 218
Chau, I., Norman, A. R., Cunningham, D., Tait, D., Ross, P. J., Iveson, T., Hill, M., Hickish, T., Lofts, F., Jodrell, D., et al. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi116 · Cited by 186
Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer
Hershman, D., Hall, M. J., Wang, X., Jacobson, J. S., McBride, R., Grann, V. R., & Neugut, A. I. (2006) · Cancer · doi:10.1002/cncr.22316 · Cited by 182
André, T., Quinaux, E., Louvet, C., Colin, P., Gamelin, E., Bouché, O., Achille, E., Piedbois, P., Tubiana-Mathieu, N., Boutan-Laroze, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2234 · Cited by 156
Killing time: The consequences of delays in radiotherapy
Mackillop, W. J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.006 · Cited by 115
Self-citationCheung, W. Y., Neville, B. A., & Earle, C. C. (2009) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181a51173 · Cited by 106
Is Minimal Access Surgery for Cancer Associated with Immunologic Benefits?
Ng, C. S. H., Whelan, R. L., Lacy, A. M., & Yim, A. P. C. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-0029-6 · Cited by 80
Evaluation of Cytokines in Donor Site Wound Fluids
Ono, I., Gunji, H., Suda, K., Iwatsuki, K., & Kaneko, F. (1994) · Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery · doi:10.3109/02844319409022010 · Cited by 75
Ahmed, S., Ahmad, I., Zhu, T., Arnold, F., Anan, G. F., Sami, A., Yadav, S. K., Alvi, R., & Haider, K. (2010) · Diseases of the Colon & Rectum · doi:10.1007/dcr.0b013e3181e78815 · Cited by 53
Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?
Berglund, Å., Cedermark, B., & Glimelius, B. (2008) · Annals of Oncology · doi:10.1093/annonc/mdm582 · Cited by 52
Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
Zeig‐Owens, R., Gershman, S. T., Knowlton, R., & Jacobson, J. S. (2009) · PubMed · Cited by 25
Cited by
Mortality due to cancer treatment delay: systematic review and meta-analysis
Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey-Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., & Aggarwal, A. (2020) · BMJ · doi:10.1136/bmj.m4087 · Cited by 1,742
Self-citationBreast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Silver, J. K., & Baima, J. (2013) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e31829b4afe · Cited by 653
Metadata
- Authors
- Biagi, J. J., Raphael, M. J., Mackillop, W. J., Kong, W., King, W. D., & Booth, C. M.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-06-08
- Volume
- 305
- Issue
- 22
- Pages
- 2335
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2019718580
- Cited by
- 632
- References
- 34
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.